Skip to content

Reduction of Emergence Delirium In Children Undergoing Adenotonsillectomy

Role of Dexmedetomidine in reduction of Post-Operative Emergence Delirium in children undergoing Adenotonsillectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240402061403N1
Enrollment
100
Registered
2024-05-02
Start date
2023-06-10
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence Delirium in children after undergoing Adenotonsillectomy in General Anesthesia. Delirium due to known physiological condition

Interventions

Intervention 1: Intervention group: Group D (n=45) received per-operative intravenous infusion of dexmedetomidine at 0.3 mcg/kg dilutes in 50 ml of normal saline over 5 minutes. Intervention 2: Contro

Sponsors

National University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: ASA-I and II pediatric patients aged 6-12 years Patients undergoing adenotonsillectomy under General Anaesthesia

Exclusion criteria

Exclusion criteria: Patients with congenital anomalies, History of ICU admission in last 3 months Cardiac or respiratory disease Patients on anti psychotics and mood stabilizers Allergic to dexmedetomidine Patients unwilling to be included in the study

Design outcomes

Primary

MeasureTime frame
Incidence of emergence delirium between the two groups who were administered dexmedetomidine and placebo. Timepoint: Pre-Operatively, Post-Operatively at 30 minutes and 1 hour. Method of measurement: PAED (pediatric assessment emergence delirium) score and Watcha delirium score.

Secondary

MeasureTime frame
MEAN TOTAL DOSE OF ANALGESIA USED AND MEAN TOTAL RECOVERY TIME (TILL DISCHARGE). Timepoint: (RECOVERY TILL DISCHARGE). Method of measurement: Visual Analogue Scale.

Countries

Pakistan

Contacts

Public ContactHafiz Arslan Arshad

National University of Medical Sciences

amcolian.arsy@gmail.com+92 51 6542119

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026